(Q38454097)

3 September 2017

1 reference

title

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research (English)

1 reference

3 September 2017

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael Maes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Gabriel Nowak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Javier R Caso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Juan Carlos Leza

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Marta Kubera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Cristiano Noto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rudi Balling

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael Berk

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

Piotr Galecki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Cai Song

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hans Klein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

2 May 2015

1 reference

3 September 2017

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

2927-2935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12035-015-9183-5

10 June 2020

exact match

0 references

cites work

A review on the acute phase response in major depression

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

So depression is an inflammatory disease, but where does the inflammation come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Lower serum vitamin E concentrations in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Association between toll-like receptors expression and major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Psychological and behavioural effects of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The monocyte-T-lymphocyte hypothesis of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Haptoglobin: old protein with new functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Haptoglobin, inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Effects of antidepressants on the production of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Impact of antidepressants on cytokine production of depressed patients in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Nitrosothiols in the immune system: signaling and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Oxidative & nitrosative stress in depression: why so much stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The impact of statins on psychological wellbeing: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Statin-associated necrotizing autoimmune myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Prevalence and management of panic attacks during infliximab infusion in psoriatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Suicide attempt in ulcerative colitis patient after 4 months of infliximab therapy--a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Putative neuroprotective agents in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

N-acetylcysteine for major depressive episodes in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Translational systems biology of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

A systems approach to dissecting immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

A systems medicine clinical platform for understanding and managing non- communicable diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

From systems biology to systems biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Causal reasoning on biological networks: interpreting transcriptional changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Static network structure can be used to model the phenotypic effects of perturbations in regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Interdisciplinary Approaches to Achieving Gendered Innovations in Science, Medicine, and Engineering1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9183-5

Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder

21 January 2018

1 reference

12 December 2020

Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression

1 reference

12 December 2020

Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab

1 reference

12 December 2020

Immune disturbances during major depression: upregulated expression of interleukin-2 receptors

1 reference

12 December 2020

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

1 reference

12 December 2020

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

1 reference

12 December 2020

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

12 December 2020

Active placebos versus antidepressants for depression

1 reference

12 December 2020

The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression

1 reference

12 December 2020

Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression

1 reference

12 December 2020

Antidepressants and the placebo response.

1 reference

12 December 2020

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.

1 reference

12 December 2020

Statin use increases the risk of depressive disorder in stroke patients: a population-based study

1 reference

12 December 2020

The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation

1 reference

12 December 2020

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

1 reference

12 December 2020

Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers

1 reference

12 December 2020

10.1007/S12035-015-9183-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 June 2020

1031070870

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25934103%20AND%20SRC:MED&resulttype=core&format=json